Diff Profiles › MTBLS5828_0002_00000001

CIDP_patient_vs_healthy_control

CIDP_patient vs healthy_control

p-value ≤ 0.05 407 significant 2025-09-26 00:00:00 Study: MTBLS5828
1424 Total Features
407 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS5828_0002_00000001
Linked study
MTBLS5828 — Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy
Comparison
CIDP_patient vs healthy_control
Group A
Samples from patients diagnosed with CIDP.. Understanding the metabolic and microbiome differences in CIDP patients compared to healthy individuals.
Group B
Samples from healthy individuals serving as controls.. Provides a baseline to identify deviations in CIDP patients.
Total features tested
1424
Significant features
407
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
PMNIPCXKCBLOJO-PPCJQXESSA-N (2S)-2-amino-3-[hydroxy-[(2R)-2-hydroxy-3-(2-methoxynonadecoxy)propoxy]phosphoryl]oxypropanoic acid down 0.05453 1.72e-27
RWXIFXNRCLMQCD-JBVRGBGGSA-N (20<i>S</i>)-propanaxadiol down 0.06739 2.81e-28
XUZBBCVOLRBWDH-QFMSAKRMSA-N (2S)-2-amino-3-[hydroxy-[(2R)-2-hydroxy-3-(2-methoxy-14-methylpentadecoxy)propoxy]phosphoryl]oxypropanoic acid down 0.05831 1.12e-25
JMWFFJATYDQZCI-HOTGVXAUSA-N — down 0.05617 2.65e-25
FMMOOAYVCKXGMF-MURFETPASA-N 9,12-Octadecadienoic acid ethyl ester down 0.07801 7.9e-25
WQTYIKZACFUZJB-SJORKVTESA-N Borreline up 12.49 6.55e-25
LGIFCELMJBBHMO-SGQFWHNCSA-N 13-((2'-<em>O</em> β-<small>D</small>-glucopyranosyl β-<small>D</small>-glucopyranosyl)oxy)docosanoic acid 6',6''-diacetate down 0.1277 4.05e-28
PMGDADKJMCOXHX-BQBZGAKWSA-N Arginyl-Glutamine up 41.23 3.42e-14
VOMKSBFLAZZBOW-UUWRZZSWSA-N (<i>R</i>)-paliperidone hexadecanoate up 26.08 6.37e-16
SDDSJMXGJNWMJY-BRHAQHMBSA-N — up 34.86 2.37e-14